Accelerated bookbuild offering Mithra

  • Placement of 3,112,975 new shares, representing c.10% of Mithra’s pre-deal outstanding share capital
  • Issue price of €8.40 per share resulting in gross proceeds of c.€26.1 million
  • An accelerated bookbuild offering was launched before markets opened and generated strong demand from international and local Life Sciences specialist as well as generalist investors, resulting in a well-covered order book
  • Transaction proceeds will be used to continue the clinical development of the company’s Estetrol-based products Estelle and Donesta, to fund the development of its generic contraceptive up to commercialization and to fund the scaling-up of the company’s product development and product platform
     
Jan De Kerpel

Transactions